Vanguard Group »

Avalo Therapeutics Ord shares owned by Vanguard Group

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $129k 10k 12.47

More positions owned by Vanguard Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Avalo Therapeutics Ord

Ikarian Capital
OrbiMed Advisors
RA Capital Management
BVF
Logos Global Management
Commodore Capital
Sio Capital Management
Affinity Asset Advisors
Vanguard Group
Geode Capital Management
Bank of America Corporation
BlackRock
BlackRock
Morgan Stanley
Efficient Wealth Management

View all funds holding Avalo Therapeutics Ord